Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 7212985, 12 pages
https://doi.org/10.1155/2017/7212985
Research Article

Comparison of the Protective Effects of Individual Components of Particulated trans-Sialidase (PTCTS), PTC and TS, against High Cholesterol Diet-Induced Atherosclerosis in Rabbits

1Laboratory of Cardiac Pathology, Heart Institute, School of Medicine, University of São Paulo, São Paulo, SP, Brazil
2Pharmaceutical Sciences Section, College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar

Correspondence should be addressed to Abdelali Agouni

Received 19 January 2017; Accepted 8 February 2017; Published 27 February 2017

Academic Editor: Alexander N. Orekhov

Copyright © 2017 Shérrira M. Garavelo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Honma, “Predictors of atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 11, no. 5, pp. 265–270, 2004. View at Google Scholar
  2. A. Yasm, D. Ozbag, M. Klnç, H. Cralk, I. Toru, and Y. Gümüşalan, “Effect of atorvastatin and ezetimibe treatment on serum lipid profile and oxidative state in rats fed with a high-cholesterol diet,” American Journal of the Medical Sciences, vol. 339, no. 5, pp. 448–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. L. Higuchi, N. Sambiase, S. Palomino et al., “Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques,” Brazilian Journal of Medical and Biological Research, vol. 33, no. 9, pp. 1023–1026, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Iyama, S. Zhang, and S.-C. Lo, “Effects of mycoplasmal LAMPs on receptor responses to steroid hormones in mammalian cells,” Current Microbiology, vol. 43, no. 3, pp. 163–169, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. Medvedeva, N. B. Baranova, A. A. Mouzykantov et al., “Extracellular vesicles of mycoplasmas and development of resistance to quinolones in bacteria,” Doklady Biochemistry and Biophysics, vol. 454, no. 1, pp. 34–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. R. N. Ikegami, J. T. Kawakami, D. S. P. Abdalla et al., “Infection and microparticles may cause complication of atherosclerotic plaques,” Journal of Diabetes & Metabolism, vol. 6, article no. 537, 2015. View at Publisher · View at Google Scholar
  7. A. S. Leroyer, H. Isobe, G. Lesèche et al., “Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques,” Journal of the American College of Cardiology, vol. 49, no. 7, pp. 772–777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Agouni, R. Andriantsitohaina, and M. C. Martinez, “Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components,” Current Vascular Pharmacology, vol. 12, no. 3, pp. 483–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Nomura, N. N. Tandon, T. Nakamura, J. Cone, S. Fukuhara, and J. Kambayashi, “High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells,” Atherosclerosis, vol. 158, no. 2, pp. 277–287, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Mesri and D. C. Altieri, “Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway,” Journal of Biological Chemistry, vol. 274, no. 33, pp. 23111–23118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. D. L. Higuchi, “Trypanosoma cruzi trans-sialidase as a new therapeutic tool in the treatment of chronic inflammatory diseases: possible action against mycoplasma and chlamydia,” Medical Hypotheses, vol. 63, no. 4, pp. 616–623, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. P. R. Crocker, “Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell–cell interactions and signalling,” Current Opinion in Structural Biology, vol. 12, no. 5, pp. 609–615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. L. D. Powell and A. Varki, “I-type lectins,” Journal of Biological Chemistry, vol. 270, no. 24, pp. 14243–14246, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. N. D. McDonald, J.-B. Lubin, N. Chowdhury, and E. F. Boyd, “Host-derived sialic acids are an important nutrient source required for optimal bacterial fitness in vivo,” mBio, vol. 7, no. 2, Article ID e02237, 15 pages, 2016. View at Publisher · View at Google Scholar
  15. M. H. Santos, R. N. Ikegami, M. M. Reis, R. Fagundes, and M. L. Higuchi, “A new therapeutic proposal for lipid lowering treatment: association of transialidase and anti-oxidant elements. An experimental study in rabbits. DALM 2007,” Journal of Clinical Lipidology, vol. 1, no. 5, article 474, 2007. View at Google Scholar
  16. C. W. Dunnett, “A multiple comparison procedure for comparing several treatments with a control,” Journal of the American Statistical Association, vol. 50, no. 272, pp. 1096–1121, 1955. View at Publisher · View at Google Scholar · View at Scopus
  17. E. C. P. Sousa, N. A. B. Chacra, J. T. Kawakami, and M. L. Higuchi, “Characterization of organic nanoparticles for the production of the topical medications,” Global Journal of Engineering Science and Research Management, vol. 3, no. 7, pp. 106–112, 2016. View at Google Scholar
  18. Y. Zhao, L. Yan, X.-M. Luo et al., “A novel PPARα agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells,” European Journal of Pharmacology, vol. 788, pp. 104–112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Higuchi, M. H. Santos, A. Roggério, J. T. Kawakami, H. G. Bezerra, and M. Canzian, “A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices,” Clinics, vol. 61, no. 5, pp. 473–478, 2006. View at Google Scholar · View at Scopus
  20. A. B. Hartopo, I. Puspitawati, P. P. R. Gharini, and B. Y. Setianto, “Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction,” Archives of Medical Science, vol. 12, no. 3, pp. 529–537, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. D. A. Chistiakov, A. N. Orekhov, and Y. V. Bobryshevy, “Cardiac extracellular vesicles in normal and infarcted heart,” International Journal of Molecular Sciences, vol. 17, no. 1, p. 63, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. F. I. Todua and M. V. Beraya, “Hemodynamic physiology in aortic arch and trigger factors of atherosclerosis,” Bulletin of Experimental Biology and Medicine, vol. 140, no. 6, pp. 664–667, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Glasgov, E. Weisenberg, C. K. Zarins, R. Stankunavicius, and G. J. Kolettis, “Compensatory enlargement of human atherosclerotic coronary arteries,” The New England Journal of Medicine, vol. 316, no. 22, pp. 1371–1375, 1987. View at Google Scholar
  24. A. N. Orekhov, V. V. Tertov, I. A. Sobenin et al., “Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation,” Journal of Lipid Research, vol. 33, no. 6, pp. 805–817, 1992. View at Google Scholar · View at Scopus
  25. V. Sukhorukov, V. Karagodin, E. Zakiev, and A. Orekhov, “Sialidases: therapeutic and antiatherogenic potential,” Current Pharmaceutical Design, vol. 22, no. 46, 2016. View at Publisher · View at Google Scholar
  26. A. N. Orekhov, V. V. Tertov, and D. N. Mukhin, “Desialylated low density lipoprotein - naturally occurring modified lipoprotein with atherogenic potency,” Atherosclerosis, vol. 86, no. 2-3, pp. 153–161, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. V. V. Tertov, V. V. Kaplun, I. A. Sobenin, E. Y. Boytsova, N. V. Bovin, and A. N. Orekhov, “Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein,” Atherosclerosis, vol. 159, no. 1, pp. 103–115, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. H. Santos, R. N. Ikegami, M. M. Reis, R. Q. Fagundes, and M. L. Higuchi, “A new therapeutic proposal for lipid lowering treatment: association of transialidase and anti-oxidant elements. An experimental study in rabbits. In: XVI International Symposium on Drugs Affecting Lipid Metabolism- DALM, 2007, New York,” Journal of Clinical Lipidology, vol. 1, article 474, 2007. View at Google Scholar
  29. S. M. Garavelo, Experimental study evaluating the effects of natural nanoparticles and trans-Sialidase—PTCTS components-combating atherosclerosis in rabbits [Ph.D. thesis], University of São Paulo, 2016, http://www.teses.usp.br/teses/disponiveis/5/5131/tde-06022017-104721/pt-br.php.